Skip to main content
. 2022 Feb 8;14(3):850. doi: 10.3390/cancers14030850

Figure 4.

Figure 4

Kaplan–Meier survival curves for (A) overall survival of patients and (B) disease-free survival of patients with NS/FS/SS TP53 mutations and patients with MS mutations of TP53 or WT (n = 39). Log-rank test was used to test for significance. p-value < 0.05 indicates significance. Patients with TP53 nonsense and splice-site mutations showed a significantly worse OS and DFS survival when compared to patients with TP miss-sense mutations or WT.